chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Could not walk; Could not move legs; Could not urinated on herself; Could not defecated on herself; Joint pain; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself), DYSCHEZIA (Could not defecated on herself) and ARTHRALGIA (Joint pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure abnormal.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself) and DYSCHEZIA (Could not defecated on herself). On an unknown date, the patient experienced ARTHRALGIA (Joint pain), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Joint pain, Chills and Headache, at an unspecified dose and frequency. On 29-Jul-2021, GAIT INABILITY (Could not walk), MOBILITY DECREASED (Could not move legs), DYSURIA (Could not urinated on herself) and DYSCHEZIA (Could not defecated on herself) had resolved. At the time of the report, ARTHRALGIA (Joint pain), CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Blood pressure medication and Diabetes medication.
Information has been received from the patient's mother referring to a 12 year old female patient. The patient had no concomitant medication, no pertinent medical history and no drug reactions/allergies. On 17-OCT-2016 the patient was vaccinated with GARDASIL (intramuscular; strength, dosage and frequency unspecified). Five minutes after receiving the injection, the patient felt dizzy and light-headed. The patient laid down in the physician's office for about ten minutes and recovered. No treatment was given for the event and no lab diagnostic studies were performed. The causality was not reported. Additional information is not expected as physician refused to be contacted.
This spontaneous report has been received from a registered nurse referring to a patient of unknown age and unknown gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 01-JUN-2015, the patient was vaccinated a dose of PNEUMOVAX 23 (Lot #L003188, expired date 06-JUL-2016, dose and route were not provided). On 15-JUN-2016, the patient was vaccinated another dose of PNEUMOVAX 23 (lot #L040178, expired date 18-AUG-2017, dose and route were not provided). There was outside the recommendations per the PNEUMOVAX 23 prescribed information. No adverse effects were reported. Additional information has been requested.
Covid Arm at injection site 7 days after injection. Raised it hey red welt about 4? in diameter. Lasted for 2-3 days. Itching relieved with Benedryl .
Patient reported tingling in hand after 10 minutes , patient said she never gets other vaccines but she is feeling fine and left pharmacy after 15 minutes. On a follow up call she reported that tingling lasted for 30 minutes. She was feeling normal after.
pt recv vax 2OCT96 & 16OCT96 pt devel bronchial asthma, a cold, exp tightness in chest & throat;pt believed 2nd vax caused asthma;MD stated asthma was r/t vax;
Severe weakness. Back pain. Progressive and worsening productive coughing. Dizziness.
4 hours after receiving the second pfizer vaccine, I started to have a period; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non pregnant female patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: EW0162 and Expiration date was not reported), via an unspecified route of administration, administered in left arm on 16Apr2021 at 12:30 hours as dose 2, single (at the age of 54-year-old) for COVID-19 immunisation. Medical history included depression, gallbladder removed and went through menopause early (have not had a menstrual period in nearly 10 years) (all from unknown date to unknown if ongoing). Patient had no known allergies. Concomitant medications within two weeks included vitamins, minerals and an antidepressant. Patient had no other vaccine in four weeks. Historical vaccine included patient received BNT162b2 (Pfizer BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number: ER8727 and Expiration date was not reported), via an unspecified route of administration, administered in left arm on 22Mar2021 at 13:30 hours as dose 1 single (at the age of 54-year-old) for COVID-19 immunisation and experienced rash post dose 1 vaccination. Patient was not diagnosed with COVID-19, prior to vaccination and had not been tested for COVID-19, post vaccination. On 16Apr2021, at 16:00 hours (4 hours after receiving the second dose), patient started to have a period. This lasted 48 hours. Patient plan to speak to her health care provider on Monday. This happened Friday night and went through the weekend. Patient received no treatment for the events. The outcome of the event was recovered on Apr2021.  No follow-up attempts are possible. No further information is expected.
FEVER OF OVER 100 F; BODY ACHE; PAIN ON BOTH ARMS; NAUSEA; This spontaneous report received from a parent concerned a 28 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: quadriplegia, alcohol user, and non-smoker, and other pre-existing medical conditions included: Patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for coronavirus 19 prevention. No concomitant medications were reported.  On 08-APR-2021, the patient experienced body ache. On 08-APR-2021, the patient experienced pain on both arms. On 08-APR-2021, the patient experienced nausea. On 09-APR-2021, the patient experienced fever of over 100 f. Laboratory data included: Body temperature (NR: not provided) OVER 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache on 11-APR-2021, pain on both arms, and fever of over 100 f on 10-APR-2021, and nausea on 09-APR-2021. This report was non-serious.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age. On 24-APR-2013 the patient was vaccinated subcutaneously with an expired single dose of ZOSTAVAX (Lot # 672676/0069AE, expired on 03-APR-2013). No adverse effects reported. It was not reported if the patient sought medical attention. Additional information has been requested.
6cm x 8cm area of erythema over right deltoid.  Complaints of pruritis.  Treated with Benadryl 50mg po q 6hr.
patients mother states her child went to this clinic and was given a dose of the ActHIB vaccine, however the pt had previously been given 3 doses of PedvaxHIB vaccine, which was the full dose series.  This was doctor insisted that the patient receive the 4th dose of the HIB vaccine even though she completed the entire PedvaxHIB series (series of 3 to complete) .  She tried to explain to the doctor that the patient had already completed this vaccine but he did not check the state website or obtain previous medical records prior to administering this.  Patient was extremely tired after receiving this shot.
up to date w/ covid vax- booster dose listed above, developed sx and tested positive on rapid antigen test 2/3/2022
DIRECTLY AFTER RECEIVING VACCING PATIENT GOT DIZZY AND SAT DOWN - FAINTED WHILE IN THE CHAIR WHILE HER MOTHER HAD A HOLD OF HER - SHE CAME TO FAIRLY QUICKLY BUT COMPLAINED ABOUT BLURRY VISION AND TROUBLE HEARING. SHE REMAINED SITTING, DRINKING WATER - WE CALLED 911 WITH MOM'S PERMISSION - PARAMEDICS ARRIVED, CHECKED HER VITALS AND CLEARED HER TO GO WITH HER MOM - MOM SIGNED OFF WITH PARAMEDICS
CLT WOKE UP AT 5:30 AM AND SAID HE WAS THIRSTY. GRANDMA SAID HE FELT VERY WARM. CHECKED HIS TEMP AND IT WAS 102.3. GAVE MOTRIN, AND PLACED ICE PACKS TO ARM AND BACK TO HELP COOL HIM DOWN. RT ARM WAS RED, AND SLIGHTLY SWOLLEN TO THE BACK OF THE RT ARM. RECHECKED TEMP AT 7AM IT WAS 100. CHECKED AGAIN AT 10 AM AND TEMP WAS NORMAL, AND HE SAID HE WAS FINE.
severe red, 1/2 of upper  arm upper arm; fever; chills; nauseated; headaches; tingling  4-5 days duration; This non-serious case was reported by a physician via sales rep and described the occurrence of erythema of extremities in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced erythema of extremities (Verbatim: severe red, 1/2 of upper  arm upper arm), fever (Verbatim: fever), chills (Verbatim: chills), nausea (Verbatim: nauseated), headache (Verbatim: headaches) and tingling (Verbatim: tingling  4-5 days duration).  The outcome of the erythema of extremities, fever, chills, nausea and headache were not reported and the outcome of the tingling was resolved (duration 5 days).   It was unknown if the reporter considered the erythema of extremities, fever, chills, nausea, headache and tingling to be related to Shingrix.     It was unknown if the company considered the erythema of extremities, fever, chills, nausea, headache and tingling to be related to Shingrix.   Additional Information: GSK Receipt date: 22-AUG-2023 The patient's age was reported as approximately 53 years. A physician reported that a patient received dose 2 and 1 day later had severe red, 1/2 of upper arm upper arm, fever, chills, nauseated, headaches, tingling 4 to 5 days duration. Had not spoken with her to determine outcome. The reporter agrees to follow up from GSK by email.
The night he got the vaccine he had a mild fever, very fussy and did not sleep well. Woke up fussing multiple times. The next day he started to have normal stools (solid) about 4-6 times per day and it continued and got increasingly loose. Now 8 days later he is having very THICK cottage cheese yellow/greenish/gray looking diahhrea very thick and ALOT in 1 diaper. This happens multiple times per day.
Pt admitted on 8/25/2021: A 41-year-old female with no primary care physician, is followed by Doctor P of Gastroenterology for Crohn disease, and is also followed by Doctor L at Oncology for anemia.  She recently moved to and has not set up with a primary care provider there.  She was vaccinated for COVID back in March 2021.  However, she is on chronic Remicade for Crohn disease.  She gets it every 6 weeks and was due to have it this coming weekend.  One week ago, she began having malaise, generally feeling poorly, body aches, and a cough.  The following day, she began having fever and worsened symptoms and tested positive for COVID initially on August 20th.  She took it easy at home and tried to go back to work today. However, at work, she became very fatigued, dizzy, short of breath, and had to leave work and went back to an urgent care clinic.  They prescribed her prednisone, cefdinir, Symbicort, but she never got these filled. She thinks her oxygen saturation was in the upper 80s in the urgent care clinic, but does not know this for certain period. Because she was feeling worse, she came to the emergency room. Her oxygen saturation here has gone down into the upper 80s. Of note, the patient was also prescribed albuterol, azithromycin, and Breo Ellipta on August 20th. Pt discharged 8/29/2021: 41 y/o F with PMHx including Crohn disease, DM2, HTN, obesity, etc., presented to the ER c/o worsening shortness of breath, cough, fatigue, etc.  Her symptoms began 1 week prior to admission.  ABG with pO2 56 and CXR consistent with SARS pneumonia.  With concern for severe COVID-19, she was admitted to the inpatient service (SDU) for continued workup & management.
Pt's daughter called and stated her mother had been hospitalized with numbness in her legs that had progressed to her being paralyzed.  She is currently in the hospital intubated and the doctors are saying she developed GBS
Malaise; sleepy; tired; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Malaise), SOMNOLENCE (sleepy) and FATIGUE (tired) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced MALAISE (Malaise), SOMNOLENCE (sleepy) and FATIGUE (tired). On 27-Feb-2021, MALAISE (Malaise), SOMNOLENCE (sleepy) and FATIGUE (tired) had resolved.            Concomitant product use was not provided by the reporter.   After receiving vaccination, the patient felt sleepy/tired. The patient fully recovered without medical intervention the following day 27-Feb-2021. The patient was not bothered by the incident and months later received a Moderna booster.  Treatment information was not provided.
Got the third booster dose on Sept 8 and got diagnosed with COVID on 01Oct; Got the third booster dose on Sept 8 and got diagnosed with COVID on 01Oct; Got the third booster dose on Sept 8; Got the third booster dose on Sept 8; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A patient of unspecified age and gender received third (Booster) dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0187, Expiration date: 30Nov2021) via an unspecified route of administration on 08Sep2021 as dose 3 (booster), single for covid-19 immunization. Medical history included rheumatoid arthritis start and stop date unknown. Concomitant medication(s) included methotrexate (METHOTREXATE, 17.5 mg); abatacept (ORENCIA). Patient previously took first and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported, Expiration date: not reported) on an unspecified dates as single doses for COVID-19 immunization. On 01Oct2021, patient was diagnosed with COVID-19. On 01Oct2021, patient underwent lab tests and procedures which included sars-cov-2 test-got COVID. The outcome of all events was unknown.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Shakiness-Medium, Systemic: Tachycardia-Medium, Additional Details: metalic taste in mouth, heart racing
Coughing, stuffy nose, severe sore throat, burning sensation in mouth throat chest, chills, rash on chest, diarrhea, difficultly swallowing, swollen glands, loss of appetite
Pt recv vax on 11/2/98; on 11/4/98 pt exp fever (101-103), flu-like sx; dx=rxn to HepB vax
Redness; Swelling; This case was reported by a pharmacist via sales rep and described the occurrence of erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced erythema and swelling. On an unknown date, the outcome of the erythema and swelling were recovered/resolved.   It was unknown if the reporter considered the erythema and swelling to be related to Shingrix.     Additional Information: GSK Receipt Date: 21-OCT-2022 Reporter's Comment: The patient had redness and swelling for approximately one week after having received 1st dose of Shingrix.
A vial that has been opened for 9 days was administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A vial that has been opened for 9 days was administered) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A vial that has been opened for 9 days was administered). On 25-Aug-2021, EXPIRED PRODUCT ADMINISTERED (A vial that has been opened for 9 days was administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product was not provided Treatment information was not provided  CASE CROSSLINKED TO MOD21-135951, MOD21-135963
Swelling, redness, vesicles tenderness over 8"x5" area right upper arm. Treated with cold compress and 2 pack pediapred.
Employee states had normal soreness first few days, four days after injection started to have left shoulder pain, Full range of muscle but very painful, interfered with ADL's.
Community Acquired Pneumonia in left lower lobe with no evidence of plural effusion, negative for pneumothorax; got really run down; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PNEUMONIA (Community Acquired Pneumonia in left lower lobe with no evidence of plural effusion, negative for pneumothorax) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PNEUMONIA (Community Acquired Pneumonia in left lower lobe with no evidence of plural effusion, negative for pneumothorax) (seriousness criterion medically significant) and FATIGUE (got really run down). At the time of the report, PNEUMONIA (Community Acquired Pneumonia in left lower lobe with no evidence of plural effusion, negative for pneumothorax) had not resolved and FATIGUE (got really run down) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Chest X-ray: abnormal (abnormal) Community Acquired Pneumonia in left lower lobe with no evidence of plural effusion, negative for pneumothorax. On 26-Mar-2021, SARS-CoV-2 test negative: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based in the current information and the temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based in the current information and the temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
The kinrix was given to early for the pt.  The DTap and the polio immunizations should have been given separately.  Pt did not have any adverse effects.
Patient developed at fever 1-2 hours after receiving her FIRST round of vaccinations HIB and Dtap on 1/24/14. Febrile for 2 days with increasing fever to 102.7 and then vomiting. She was brought to the emergency room where she received an IV with IV fluids, performed bloodwork, straight catheterized for urine. Pt was discharged from the hospital, but never improved and quickly declined in health. Continued vomiting, not tolerating fluids and becoming increasingly lethargic. Was seen by the pediatrician the next day and then directly admitted to the hospital. She received IV antibiotics, IV fluids. Spinal tap was done at the hospital and revealed that she had Meningitis. She remained in the Hospital for days to complete her daily IV antibiotic treatment and to received IV fluids. During the hospital stay, she had a cranial ultrasound performed and was seen by a Pediatric Neurologist from Hospital. Myself and my husband were treated prophylactically with Rifampin for meningitis exposure.  Total hospitalization days 10. Total days sick 13.
Acute onset of sharp, twisting pain in left forearm at 10 mins post vaccination. Reporting complaints of slight tingling of fingers without loss of ROM or strength. No previous history of cervical spine or upper extremity injury.
Vaccines given ant 11:00 am. At 11:03 Pt felt dizzy after vaccination. Became pale, vomiting. Placed in room. BP 103/73, HR106, RR-16, SaO2 97%. Felt better after approx 5 min  11:34- Pt sitting in room no longer vomiting. Denies feeling faint or nauseated. Sat on exam table for approx 10-15min, drinking water. BP-108/68, HR82, RR-16 SaO2 98%. Color looks good. Pt denied any symptoms and was discharged to home
At 11:40 am Patient was facing right side. Left arm hang along side waist. Left arm cleaned with alcohol prep in a circle motion from enter to outer. Syringe filled with Jannsen (J&J) vaccines 0.5 ml was inserted in Patient's arm. I aspirated to make sure I wasn't in a vessel. Syringe filled with blood and I immediately pulled out and call for help. Site showed no signs of redness, swelling, or bruising.  Patient stated she was fine and wasn't in any way in pain. Vaccines wasn't injected. Syringe was placed in sharps. Patient spoke with (lead) after observing and wanted to proceed with injection in the right arm.
inside of my mouth irritated; inside of my mouth so red; lips inside mouth red; lips inside mouth irratated; lips inside mouth dry; inside of my mouth so dry; This spontaneous case was reported by a consumer and describes the occurrence of STOMATITIS (inside of my mouth irritated), ORAL MUCOSAL ERYTHEMA (inside of my mouth so red), LIP ERYTHEMA (lips inside mouth red), CHEILITIS (lips inside mouth irratated) and LIP DRY (lips inside mouth dry) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced STOMATITIS (inside of my mouth irritated), ORAL MUCOSAL ERYTHEMA (inside of my mouth so red), LIP ERYTHEMA (lips inside mouth red), CHEILITIS (lips inside mouth irratated), LIP DRY (lips inside mouth dry) and DRY MOUTH (inside of my mouth so dry). At the time of the report, STOMATITIS (inside of my mouth irritated), ORAL MUCOSAL ERYTHEMA (inside of my mouth so red), LIP ERYTHEMA (lips inside mouth red), CHEILITIS (lips inside mouth irratated), LIP DRY (lips inside mouth dry) and DRY MOUTH (inside of my mouth so dry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Slow itch starting around 7 pm. Started on both legs. About 7:30 pm legs started itching more but still didn't realize. Between 8-8:30 pm more itching moving up my stomach, arms and back. My husband saw a rash on my body. I called the pharmacist around 8:50 pm. Pharmacist suggested to take BENADRYL or CLARITIN. He also said if I felt worse call 911. My husband went to get CLARITIN. While my husband was gone I felt my lip a little numb feeling. I took a CLARITIN by 9:30 pm and started feeling better. I was mildly itchy the next day. The CLARITIN was a 24 hr dosage.
3" area of redness at injection site c/o itch, area is raised and warm.
Since receiving my 4th dose of my Moderna vaccine, my taste has been affected. I can still taste things but everything tastes bland. On my tongue and around the inside of my lips I have noticed a tingling sensation as well.